Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

View:
Post by ZeoGak on Aug 14, 2023 11:59pm

Shiseido

[url=https://https://www.cosmeticsdesign-asia.com/Article/2023/08/15/shiseido-s-japan-business-at-risk-without-major-reforms-coo][/url]
Comment by ZeoGak on Aug 15, 2023 12:03am
https://www.cosmeticsdesign-asia.com/Article/2023/08/15/shiseido-s-japan-business-at-risk-without-major-reforms-coo
Comment by bluemoons20 on Aug 15, 2023 10:00am
Well if they are looking for  growth opportunities  to  push the business forward.  RCH-01  may be the product to do it.   Since there is a new COO  maybe everything was on hold the last while  as he figured out  what his business needed. It seems to say that the Japanese market will not  grow the company so they need outside  markets   ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities